Medtronic Sues NuVasive, Again (Orthopedics This Week)
NuVasive, Inc. and Medtronic, Inc. are in a dispute again over some Gary Michelson-based technology.
NuVasive disclosed in an 8-K SEC filing on August 23 that Medtronic, through its subsidiary, Warsaw Orthopedic, Inc., was asserting additional patent claims against the company in ongoing patent litigation.
Specifically, the complaint filed by Medtronic in the U.S. District Court for the Northern District of Indiana alleges that various NuVasive spinal implants (including its CoRoent XL family of spinal implants) infringe U.S. Patent No. 8,021,430, and that NuVasive's Osteocel Plus bone graft product infringes U.S. Patent No. 5,676,146 C2. These additional patents expire in the next three to four years. Osteocel Plus is the product NuVasive acquired from Orthofix International N.V. and was called Trinity.
NuVasive strongly denies infringing any valid claims of these additional patents and intends to defend the lawsuit vigorously. NuVasive is assessing all offensive and defensive measures available to it, including the assertion of counterclaims and the use of administrative reexamination procedures available through the U.S. Pat...
